Vitamin D deficiency and its health effects

Česká verzia

Authors: Pavel Horák
Authors place of work: III. interní klinika –nefrologická, revmatologická, endokrinologická LF UP a FN Olomouc
Published in the journal: Vnitř Lék 2019; 65(11): 724-727
Category: Actualities

Summary

Vitamin D₃ cholecalciferol is produced from its cholesterol precursors in the skin under the influence of ultraviolet calc. Its subsequent hydroxylation in the liver and kidneys leads to the formation of its most active metabolite calcitriol, which plays one of the key roles in the management of calcium phosphate metabolism. However, it also has the ability to regulate the function of a number of cells and tissues that express the vitamin D receptor. The most widespread method to evaluate the status of vitamin D in the body is to measure serum levels of its metabolite 25 hydroxyvitamin D – 25 (OH) D. Optimal values range between 75–125 nmoll / l. Its deficit is widespread in the human population worldwide and has a significant impact on the prevalence of metabolic bone diseases. Its deficiency may support the dysfunction of many other body systems. Ensuring optimal levels of vitamin D in the population is a challenge not only for health care and especially for government administration.

Keywords:

bone diseases – calciferol – calcium metabolism – deficiency – pleiotropic effect

Zdroje

Haussler MR. Vitamin D receptors: nature and function. Ann Revs Nutr 1986; 6: 527–562. Dostupné z DOI: <http://dx.doi.org/10.1146/annurev.nu.06.070186.002523>.
Pavek P, Pospechova K, Svecova L et al. Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. Biochem Pharmacol 2010; 79(2): 277–287. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bcp.2009.08.017>.
Adorini A, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008; 4(8): 404–412. Dostupné z DOI: <http://dx.doi.org/10.1038/ncprheum0855>.
Hart GR. Overview of vitamin D measurement and methodologies. Immunodiagnostic systems 2005; 2: 1–9.
Pludowski P, Holick MF, Grant WB et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 2018; 175: 125–135. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jsbmb.2017.01.021>.
Vieth R, Cole DE, Hawker GA et al. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001; 55(12): 1091–1097. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.ejcn.1601275>.
Välimäki VV, Alfthan H, Lehmusklallio E et al. Vitamin D status as a determinant of peak bone mass in young finnish men. J Clin Endocrinol Metabol 2004; 89(1): 76–80. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2003–030817>.
Holick MF, Siris ES, Binkley N et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90(6): 3215–3224. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2004–2364>.
Greene-Finestone LS, Berger C, de Groh M et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporosis Int 2011; 22(5): 1389–1399. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–010–1362–7>.
Pludowski P, Grant WB, Bhattoa HP et al. Vitamin D status in central Europe. Int J Endocrinol 2014; 2014:589587. doi: Dostupné z DOI: <http://dx.doi.org/10.1155/2014/589587>.
Dort J, Bayer M, Dortová E et al. Vitamin D and other parameters of calcium and phosphate metabolism in healthy term newborns after birth. Osteol Bull 2007; 12(2): 70–73.
Sochorová L, Hanzlíková L, Černá M et al. Assessment of vitamin D status in Czech children. Cent Eur J Public Health 2018; 26(4): 260–264. Dostupné z DOI: <http://dx.doi.org/10.21101/cejph.a5386>.
Bischofova S, Dofkova M, Blahova J et al. Dietary Intake of Vitamin D in the Czech Population: A Comparison with Dietary Reference Values, Main Food Sources Identified by a Total Diet Study. Nutrients 2018; 10(10): pii: E1452. Dostupné z DOI: <http://dx.doi.org/10.3390/nu10101452>.
Cashman KD, Dowling KG, Škrabáková Z et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr 2016; 103(4): 1033–1044. Dostupné z DOI: <http://dx.doi.org/10.3945/ajcn.115.120873>.
Husain NE, Badie Suliman AA, Abdelrahman I et al. Vitamin D level and its determinants among Sudanese Women: Does it matter in a sunshine African Country? J Family Med Prim Care 2019; 8(7): 2389–2394. Dostupné z DOI: <http://dx.doi.org/10.4103/jfmpc.jfmpc_247_19>.
Geusens P, van Brusel MS, Lems WF. Osteoporosis and fracture risk: pathogenesis, epidemiology, clinical aspects and diagnosis. In: Bijlsma JW (ed). Eular compendium on rheumatic diseases. BMJ Publishing: London 2009: 523–538. ISBN 978–1905545353.
McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93(1): 69–77. Dostupné z DOI: <http://dx.doi.org/10.1016/0002–9343(92)90682–2>.
Krexner E, Resch H, Pietschmann P et al. Vitamin D status in residents of a long-term-care geriatric hospital in Vienna. Osteologie 1996; 5: 13–18.
Chapuy MC, Durr F, Chapuy P. Age-related changes in parathyroid hormone and 25 hydroxycholecalciferol levels. J Gerontol 1996; 38(1): 19–22. Dostupné z DOI: <http://dx.doi.org/10.1093/geronj/38.1.19>.
Cantorna MT, Mahon BD. D hormone and immune system. J Rheumatol Suppl 2005; 76: 11–20.
Verhaar HJ, Samson MM, Jansen PAF et al. Muscle strength, functional mobility and vitamin D in older women. Aging (Milano) 2000; 12(6): 455–460.
Judd S, Tangpricha V. Vitamin D Deficiency and Risk for Cardiovascular Disease. Am J Med Sci 2009; 338(1): 40–44. Dostupné z DOI: <http://dx.doi.org/10.1097/MAJ.0b013e3181aaee91>.
Kheiri B, Abdalla A, Osman M et al. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertension 2018; 24: 9. Dostupné z DOI: <http://dx.doi.org/10.1186/s40885–018–0094–4>.
Skowron K, Pawlicka I, Gil K. The role of vitamin D in the pathogenesis of ocular diseases. Folia Med Cracov 2018; 58(2): 103–118. Dostupné z DOI: <http://dx.doi.org/10.24425/fmc.2018.124662>.
Dankers W, Colin EM, van Hamburg JP et al. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential Front Immunol 2016; 7: 697. Dostupné z DOI: <http://dx.doi.org/10.3389/fimmu.2016.00697>.
Konduru M, Sastry KS, Fatima A et al. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol 2018; 31(2): 74–86. Dostupné z DOI: <http://dx.doi.org/10.1159/000485132>.
Rosa J, Šenk F, Palička V et al. Diagnostika a léčba postmenopauzální osteoporózy. Stanovisko Společnosti pro metabolická onemocnění skeletu ČLS JEP 2015. Osteol Bull 2015; 20(4): 150–168.
Bouillon R, van Schoor NM, Gielen E et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocr Metab 2013; 98(8): E1283–304. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013–1195>.
Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and preventiopn of vitamin D deficiency: an Endrocrine Society clinical practice quideline. J Clin Endocrinol Metab 2011; 96(7): 1911–1930. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011–0385>.
Bischoff-Ferrari HA, Shao A, Dawson-Hughes B et al. Benefit-Risk assessment of vitamin D supplemenation. Osteopos Int 2010; 21(7): 1121–1132. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–009–1119–3>.
Kalvachová B. Vitamin D – nové poznatky a endokrinní mikrosystémy katcitriolu. Osteol Bull 2007; 12(2): 62–67.